Effect of irbesartan on clyclooxygenase-2 expression in experimental type 2 diabetic rat
10.3760/cma.j.issn.1008-1372.2010.07.013
- VernacularTitle:厄贝沙坦对2型糖尿病大鼠肾脏组织环加氧酶-2表达的影响
- Author:
Hua LI
;
Chuanwen XU
;
Yang WU
;
Yanmei XU
;
Weicong WU
;
Jie HUANG
- Publication Type:Journal Article
- Keywords:
Tetrazoles/PD;
Biphenyl compounds/PD;
Diabetes mellitus/DT/PA/ME;
Prostaglandin-endoperoxide synthases/ME;
Kidney/ME
- From:
Journal of Chinese Physician
2010;12(7):903-906
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of angiotensin Ⅱ (AngⅡ) type 1 receptor block irbesartan on the expression of renal cyclooxygenase-2 ( COX-2 ) in rats with type 2 diabetes mellitus.Methods 18 rats were divided into control group, diabetes mellitus group and treating group.Immunohistochemistry was used to measure the expression of COX-2, matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).The urinary TXB2,6-Ket-PGF1 αconcentration was determined by radioimmunoassay at the 6th week .Results There was an increasing expression of COX-2,TIMP-1 and decreasing M MP-9 ( COX-2:0.39 ± 0.02 vs 0.24 ± 0.04, TIMP :0.41 ± 0.03 vs 0.24 ± 0.02,MMP-9:0.24 ± 0.02 vs 0.32 ± 0.02, P ＜ 0.05 ) expression in the diabetes mellitus group ( P ＜ 0.05 ).Irbesartan could increase MMP-9 (0.29 ± 0.03 ) and depress TIMP-1 (0.34 ± 0.02) expression through inhibiting the expression of COX-2(0.31 ± 0.03) in renal tissue.Conclusions COX-2 was involved in the pathogenesis of the injury of type 2 diabetic nephropathy.Irbesartan might exert its renoprotective effects through inhibiting COX-2 activity, modulating the expression of MMP-9 and TIMP-1.
